There were 1,740 press releases posted in the last 24 hours and 442,638 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image